Bio-Techne (NASDAQ: TECH) reported Q1 EPS of $0.84, $0.05 better than the analyst estimate of $0.79. Revenue for the quarter came in at $130.6 million versus the consensus estimate of $127.47 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.